Screening for Anderson-Fabry Disease in patients with left ventricular hypertrophy and disease-related red flags

29 August 2025 (13:15 - 14:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Joana Certo Pereira

Hospital de Santa Cruz, Carnaxide (Portugal)

7 More presentations in this session

Presentation thumbnail

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Doctor Y. Chen (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

FollowME Fabry Pathfinders real-world registry in Spain and Portugal: cardiac and renal outcomes with migalastat in patients with Fabry disease

Professor O. Azevedo (Guimaraes, PT)

Abstract Slides Video

Presentation thumbnail

Apical hypertrophic cardiomyopathy: could it be Fabry?

Doctor S. Findlay (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Prevalence of pseudo-delta wave in Anderson-Fabry disease and challenges in differentiating from ventricular pre-excitation

Doctor S. Serratore (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Doctor E. Martins (Porto, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Fabry disease

The Event

Event poster

ESC Congress 2025

29 August 2025 13:15 CET

You may be interested in

Congress Presentation

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Congress Presentation

The spectrum of hypertrophic cardiomyopathies: where is fabry

Congress Presentation

Red flags plays a significant role in the diagnosis of Anderson–Fabry disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources